FSGS news

First Trust SMID Growth Strength · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Scienmag: Latest Science and Health News · 29 Oct 2026, 03:19 UTC
Land plants arrived tens of millions of years later than we thought, spore
1.5% of FSGS
wallstreet:online · 29 Oct 2026, 02:05 UTC
Northern Trust Celebrates 30 Years in Singapore
1.1% of FSGS
Investing.com · 28 Oct 2026, 22:21 UTC
Sprouts Q3 2026 slides show growth amid traffic decline, shares plunge By Investing.com
1.1% of FSGS
Bloomberg Business · 28 Oct 2026, 21:24 UTC
Sprouts Slashes Outlook After Cyclospora Outbreak Hit Sales
1.1% of FSGS
Where to buy FSGS
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Investing.com · 28 Oct 2026, 23:30 UTC
DexCom EVP Sadie Stern sells $201,660 in shares By Investing.com
1.1% of FSGS
Investing.com · 28 Oct 2026, 20:12 UTC
Sprouts Farmers Market tumbles 15% on weak guidance and Q3 miss By Investing.com
1.1% of FSGS
Where to buy FSGS
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
The Motley Fool · 28 Oct 2026, 19:00 UTC
Coinbase vs. Interactive Brokers: Which Financial Stock Has More Long-Term Upside?
1.1% of FSGS
Investing.com · 28 Oct 2026, 15:42 UTC
Incyte earnings up next: Analysts eye loss amid pipeline gains By Investing.com
1.2% of FSGS
Investing.com · 28 Oct 2026, 13:42 UTC
Exelixis stock hits all-time high at 65.62 USD By Investing.com
1.2% of FSGS
Investing.com · 28 Oct 2026, 15:13 UTC
Sprouts Farmers Market faces earnings test on affordability By Investing.com
1.1% of FSGS
Market Screener · 28 Oct 2026, 14:41 UTC
Adagene Inc. Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte?S Inca33890 in Patients with Microsatellite Stable Colorectal Cancer
1.2% of FSGS
Investing.com · 28 Oct 2026, 22:24 UTC
Evercore Q3 2026 slides: record results, #3 in advisory fees By Investing.com
0.9% of FSGS
Seeking Alpha · 28 Oct 2026, 17:17 UTC
Acadian Asset Management Q3 2026 Earnings Preview | Seeking Alpha
1.0% of FSGS
Seeking Alpha · 28 Oct 2026, 18:32 UTC
RenaissanceRe anticipates Q4 retained net investment income around $325M amid portfolio duration extension to 4.2 years (NYSE:RNR) | Seeking Alpha
1.0% of FSGS
Seeking Alpha · 28 Oct 2026, 18:30 UTC
RenaissanceRe Holdings Ltd. (RNR) Q3 2026 Earnings Call Transcript | Seeking Alpha
1.0% of FSGS
Seeking Alpha · 28 Oct 2026, 21:04 UTC
Evercore Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:EVR) 2026-10-28 | Seeking Alpha
0.9% of FSGS
Morningstar · 28 Oct 2026, 23:00 UTC
Trick or Treat? Index Funds Beat Their Benchmarks More Often Than Active Funds Over the Past Decade
0.8% of FSGS
Investing.com · 28 Oct 2026, 19:44 UTC
Earnings call transcript: Essex Property Trust tops Q3 2026 EPS forecast, shares fall By Investing.com
0.9% of FSGS
Seeking Alpha · 28 Oct 2026, 21:01 UTC
Jones Lang LaSalle Incorporated 2026 Q3 - Results - Earnings Call Presentation (NYSE:JLL) 2026-10-28 | Seeking Alpha
0.9% of FSGS
The Manila times · 28 Oct 2026, 11:11 UTC
Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte's INCA33890 in Patients with Microsatellite Stable Colorectal Cancer
1.2% of FSGS

FSGS news

Where to buy FSGS

Where to buy FSGS